Alife Health has announced a partnership with US Fertility to pilot Embryo Assist, an AI-powered software tool designed to enhance embryo cataloging and laboratory operations. US Fertility, the largest partnership of physician-owned fertility practices in the US, performs over 50,000 IVF retrieval cycles annually.
The Embryo Assist software integrates with laboratory microscopes to streamline embryo image capture and data collection. The cloud-based platform provides real-time laboratory updates and comprehensive audit trails for each embryo, enabling embryologists to access current data for decision-making.
“Our partnership with Alife marks a significant advancement in our laboratory capabilities,” said Kate Devine, MD, Medical Director and Chief Research Officer of US Fertility. “By integrating AI and data-driven tools into our IVF processes, we aim to continue delivering exceptional care to our patients while providing them with further insight into the precision and consistency of our laboratories.”
US Fertility, which has helped more than 225,000 individuals and couples through assisted reproductive technology, will use the pilot to enhance their data capabilities and patient integration across their network of over 200 physicians.
“Alife is honored to partner with US Fertility to bring our cutting-edge AI solutions into their laboratories,” said Melissa Teran, CEO of Alife Health. “Through this pilot collaboration, we will equip embryologists with a powerful tool that streamlines operations and enhances clinical efficiency. Together, we are advancing IVF through innovation.”
